✦ LIBER ✦

Tolerance and efficacy of high dose doxorubicin in a sequential neoadjuvant regimen for locally advanced breast carcinoma (LABC): preliminary results of a phase II trial

✍ Scribed by Santillana, S.; Valdivia, S.; Paradi, J.; Gomez, H.; Vigil, C.; Velarde, R.; Abugattas, J.; Leon, L.; Vallejos, C.

Book ID: 122792119
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 156 KB
Volume: 35
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(99)81728-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of neoadjuvant methotre

A phase II trial of neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of patients with locally advanced breast carcinoma

✍ Louise E. Morrell; Young J. Lee; Judith Hurley; Mayda Arias; Carolyn Mies; Steph 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 2 views

## Background: Traditionally, primary surgical therapy is considered unsuitable for the treatment of patients with locally advanced breast carcinoma (labc). multiple reports have documented the efficacy of primary chemotherapy in this group of patients. the purpose of this study was to investigate

477 PUBLICATION Preliminary results of a

477 PUBLICATION Preliminary results of a phase II study of neoadjuvant treatment with docetaxel (T), doxorubicin (A) and capecitabine (X) in locally advanced or inflammatory breast cancer

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Efficacy and tolerability of chemotherap

Efficacy and tolerability of chemotherapy with modified dose-dense TCF regimen (TCF-dd) in locally advanced or metastatic gastric cancer: final results of a phase II trial

✍ Tomasello, Gianluca; Liguigli, Wanda; Poli, Rossana; Lazzarelli, Silvia; Brighen 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 220 KB

Concurrent Bevacizumab with a Sequential

Concurrent Bevacizumab with a Sequential Regimen of Doxorubicin and Cyclophosphamide Followed by Docetaxel and Capecitabine as Neoadjuvant Therapy for HER2− Locally Advanced Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group

✍ Priya Rastogi; Marc E. Buyse; Sandra M. Swain; Samuel A. Jacobs; André Robidoux; 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 570 KB

0170 Phase II trial of neoadjuvant seque

0170 Phase II trial of neoadjuvant sequential FEC100 followed by docetaxel, carboplatin and trastuzumab (TCH) for HER-2 over-expressing locally advanced breast cancer (LABC): A multi-centre study from British Columbia

✍ S. Chia; C. Bryce; G. Pansegrau; N. Macpherson; S. Ellard; D. Jepson; C. Yu; S. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Amifostine and external beam radiation t

Amifostine and external beam radiation therapy and/or high-dose rate brachytherapy in the treatment of localized prostate carcinoma: preliminary results of a phase II trial

✍ Luis A Linares; Deborah Echols 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 116 KB